Evidence map›Paper›PMID 17230229›Full record

ReviewLeukemia2007

The pathogenesis of MALT lymphomas: where do we stand?

X Sagaert, C De Wolf-Peeters, H Noels, M Baens

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Leukemia, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. An unusual presentation of gastric mucosa-associated lymphoid tissue (MALT)-type lymphoma.Journal of community hospital internal medicine perspectives · 2016
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Case report: Colonic MALT lymphoma.Journal of gastrointestinal cancer · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

X SagaertDepartment of Morphology and Molecular Pathology, University of Leuven, Leuven, Belgium. xavier.sagaert@uz.kuleuven.ac.be
C De Wolf-Peeters
H Noels
M Baens
KU Leuven · BEVlaams Instituut voor Biotechnologie · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is a heterogeneous form of a B-cell non-Hodgkin's lymphoma with extranodal location. The gastrointestinal tract is the most common site of disease, but involvement of multiple other organ systems has been documented. Four translocations, t(11;18)(q21;q21), t(1;14)(p22;q32), t(14;18)(q32;q21) and t(3;14)(p13;q32), are specifically associated with MALT lymphoma. Remarkably, the genes targeted by at least three of these translocations are involved in one and the same pathway, leading to the activation of nuclear factor-kappaB (NF-kappaB). This review presents MALT lymphoma as a model of how sustained inflammation increases the risk of genotoxic insults and how these genetic events initiate oncogenesis.

Indexed as

AnimalsAntigens, BacterialAutoantigensB-Lymphocyte SubsetsCaspasesChromosomes, Human, Pair 1Chromosomes, Human, Pair 11Chromosomes, Human, Pair 14Chromosomes, Human, Pair 18Chronic DiseaseGastritisGastrointestinal NeoplasmsGene Expression Regulation, NeoplasticGenes, ImmunoglobulinHelicobacter InfectionsHelicobacter pyloriAntigens, BacterialAutoantigensCaspasesImmunoglobulin Heavy ChainsMALT1 protein, humanMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNeoplasm ProteinsNF-kappa BOncogene Proteins, Fusion

Identifiers

PMID17230229
OpenAlexW2053957890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.